The same results were obtained in FGL2−/− mice prechallenged with GL261-FGL2KO cells (Fig. 3j), showing that tumor cell-specific FGL2KO is crucial to induce this systemic adaptive immune response. The gene discussed is FGL2; the disease is neoplasm.